These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30739808)

  • 1. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Isıklar A; Safer U; Binay Safer V; Yiyit N
    Clin Nutr; 2019 Apr; 38(2):964-965. PubMed ID: 30739808
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kaido T; Kamo N; Uemoto S
    Clin Nutr; 2019 Apr; 38(2):967. PubMed ID: 30739810
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation.
    Choudhary NS; Saigal S; Saraf N; Mohanka R; Rastogi A; Goja S; Menon PB; Mishra S; Mittal A; Soin AS
    Clin Transplant; 2015 Mar; 29(3):211-5. PubMed ID: 25594826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pre-transplant sarcopenia on the estimation of standard liver volume in living-donor liver transplant candidates: risk factor for post-transplant small-for-size syndrome? A retrospective study.
    Pravisani R; Hidaka M; Baccarani U; Ono S; Isola M; Kugiyama T; Soyama A; Adachi T; Hara T; Hamada T; Pecquenard F; Risaliti A; Eguchi S
    Transpl Int; 2020 Oct; 33(10):1282-1290. PubMed ID: 32621775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.
    Kaido T; Tamai Y; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Hammad A; Inagaki N; Uemoto S
    Nutrition; 2017 Jan; 33():195-198. PubMed ID: 27649861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY.
    Anastácio LR; Ferreira LG; Ribeiro HS; Diniz KGD; Lima AS; Correia MITD; Vilela EG
    Arq Bras Cir Dig; 2019; 32(2):e1434. PubMed ID: 31038559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation.
    Shirai H; Kaido T; Hamaguchi Y; Yao S; Kobayashi A; Okumura S; Kamo N; Yagi S; Okajima H; Uemoto S
    Nutrition; 2018 Jan; 45():1-10. PubMed ID: 29129228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
    Itoh S; Yoshizumi T; Kimura K; Okabe H; Harimoto N; Ikegami T; Uchiyama H; Shirabe K; Nishie A; Maehara Y
    Anticancer Res; 2016 Jun; 36(6):3029-34. PubMed ID: 27272822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.
    Harimoto N; Yoshizumi T; Izumi T; Motomura T; Harada N; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Nishie A; Kamishima T; Kusaba R; Shirabe K; Maehara Y
    Transplant Proc; 2017 Nov; 49(9):2144-2152. PubMed ID: 29149975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Impact of sarcopenia on survival in patients undergoing living donor liver transplantation".
    Safer U; Tasci I; Binay Safer V; Doruk H
    Am J Transplant; 2013 Sep; 13(9):2505. PubMed ID: 23915024
    [No Abstract]   [Full Text] [Related]  

  • 13. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of body composition on survival and morbidity after liver resection in hepatocellular carcinoma patients.
    Kroh A; Uschner D; Lodewick T; Eickhoff RM; Schöning W; Ulmer FT; Neumann UP; Binnebösel M
    Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):28-37. PubMed ID: 30115516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
    Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
    Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
    Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
    Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased Incidence of Acute Cellular Rejection in Low-Muscle-Mass Recipients After Living-donor Liver Transplantation.
    Wakabayashi T; Shinoda M; Obara H; Kitago M; Yagi H; Abe Y; Matsubara K; Yamada Y; Oshima G; Hirukawa K; Mizota T; Hibi T; Itano O; Hoshino K; Kuroda T; Kitagawa Y
    Transplant Proc; 2018 Dec; 50(10):3626-3634. PubMed ID: 30577248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenia is a prognostic factor in living donor liver transplantation.
    Masuda T; Shirabe K; Ikegami T; Harimoto N; Yoshizumi T; Soejima Y; Uchiyama H; Ikeda T; Baba H; Maehara Y
    Liver Transpl; 2014 Apr; 20(4):401-7. PubMed ID: 24357065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Xue FS; Liu YY; Liu Q
    Liver Transpl; 2018 Jun; 24(6):845-846. PubMed ID: 29603571
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative loss of psoas muscle is associated with patient survival in living donor liver transplantation.
    Chae MS; Moon KU; Jung JY; Choi HJ; Chung HS; Park CS; Lee J; Choi JH; Hong SH
    Liver Transpl; 2018 May; 24(5):623-633. PubMed ID: 29365358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.